- Home
- IMCC vs LSBPW Comparison
IMCC vs LSBPW Comparison
Compare IMCC & LSBPW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCC
- LSBPW
- Stock Information
- Founded
- IMCC 1980
- LSBPW N/A
- Country
- IMCC Israel
- LSBPW China
- Employees
- IMCC N/A
- LSBPW 758
- Industry
- IMCC Medicinal Chemicals and Botanical Products
- LSBPW Biotechnology: Pharmaceutical Preparations
- Sector
- IMCC Health Care
- LSBPW Health Care
- Exchange
- IMCC Nasdaq
- LSBPW Nasdaq
- Market Cap
- IMCC 5.0M
- LSBPW N/A
- IPO Year
- IMCC N/A
- LSBPW N/A
- Fundamental
- Price
- IMCC $2.23
- LSBPW $0.07
- Analyst Decision
- IMCC
- LSBPW
- Analyst Count
- IMCC 0
- LSBPW 0
- Target Price
- IMCC N/A
- LSBPW N/A
- AVG Volume (30 Days)
- IMCC 11.8K
- LSBPW N/A
- Earning Date
- IMCC 11-11-2024
- LSBPW N/A
- Dividend Yield
- IMCC N/A
- LSBPW N/A
- EPS Growth
- IMCC N/A
- LSBPW N/A
- EPS
- IMCC N/A
- LSBPW N/A
- Revenue
- IMCC $36,445,402.00
- LSBPW N/A
- Revenue This Year
- IMCC $22.59
- LSBPW N/A
- Revenue Next Year
- IMCC $20.53
- LSBPW N/A
- P/E Ratio
- IMCC N/A
- LSBPW N/A
- Revenue Growth
- IMCC N/A
- LSBPW N/A
- 52 Week Low
- IMCC $1.13
- LSBPW N/A
- 52 Week High
- IMCC $8.10
- LSBPW N/A
- Technical
- Relative Strength Index (RSI)
- IMCC 41.06
- LSBPW N/A
- Support Level
- IMCC $2.02
- LSBPW N/A
- Resistance Level
- IMCC $2.15
- LSBPW N/A
- Average True Range (ATR)
- IMCC 0.14
- LSBPW 0.00
- MACD
- IMCC -0.01
- LSBPW 0.00
- Stochastic Oscillator
- IMCC 19.15
- LSBPW 0.00
About IMCC IM Cannabis Corp.
IM Cannabis Corp is a Canada-based international medical cannabis company. It operates in the field of medical cannabis, through Focus Medical Herbs Ltd. (Focus), which holds a cultivation license to breed, grow, and supply medical cannabis products The majority of its revenues are generated from sales of medical cannabis products to customers in Israel. The remaining revenues are generated from sales of medical cannabis, as well as other products, to customers in Germany. Geographically, the majority is from Israel.
About LSBPW LakeShore Biopharma Co. Ltd
LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.